In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.
Blood Advances
Anekpuritanang, Tauangtham T; Klairmont, Matthew M MM; Gradowski, Joel J; Hagiwara, Kohei K; Bailey, Nathanael G NG; Chandra, Pranil P; Liu, Yiwei Y; Mulder, Heather L HL; Easton, John J; Zhang, Jinghui J; Martin, Michael G MG; Owczarczyk, Anna B AB; Dunlap, Jennifer B JB; Fan, Guang G; Press, Richard D RD; Raess, Philipp W PW